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Stat3 as an Oncogene
without known requirements for extracellular polypep-Jacqueline F. Bromberg,* Melissa H. Wrzeszczynska,*
tides) is often associated with growth dysregulation.Geeta Devgan,* Yanxiang Zhao,² Richard G. Pestell,³
For example, the development of the antiviral state orChris Albanese,³ and James E. Darnell, Jr.*§
growth restraint secondary to either IFN-a or IFN-g*Laboratory of Molecular Cell Biology
treatment requires transcriptionally competent Stat1²Laboratory of Molecular Biophysics
(Bromberg et al., 1996; Horvath and Darnell, 1996) andThe Rockefeller University
mice lacking Stat1 form chemically induced tumors ofNew York, New York 10021-6399
the skin more easily than wild-type animals (Kaplan et³The Albert Einstein Cancer Center
al., 1998). Various stages of lymphocyte or monocyteDepartment of Developmental and Molecular Biology
development depend on Stats 3, 4, and 6 (Kaplan et al.,and Department of Medicine
1996; Takeda et al., 1996, 1998, 1999; Thierfelder et al.,Albert Einstein College of Medicine
1996); development of breast epithelium requires Stat5ABronx, New York 10461
(Liu et al., 1997; Teglund et al., 1998), and proper male
growth hormone response demands Stat5B (Udy et al.,
1997; Teglund et al., 1998). A growing number of tumor-Summary
derived cell lines as well as samples from human can-
cers are reported to contain constitutively activatedSTATs are latent transcription factors that mediate
STAT proteins, very frequently Stat3 (Garcia and Jove,cytokine- and growth factor±directed transcription. In
1998). For example, all src transformed cell lines exhibitmany human cancers and transformed cell lines, Stat3
constitutively activated Stat3 (Yu et al., 1995). Moreover,
is persistently activated, and in cell culture, active
dominant-negative Stat3 suppresses src transformation
Stat3 is either required for transformation, enhances
without having any effect on ras transformation (Brom-
transformation, or blocks apoptosis. We report that
berg et al., 1998; Turkson et al., 1998). Cell lines from
substitution of two cysteine residues within the C-ter-
multiple myelomas that have become growth factor in-
minal loop of the SH2 domain of Stat3 produces a dependent require constitutively active Stat3 to protect
molecule that dimerizes spontaneously, binds to DNA, against apoptosis (Catlett-Falcone et al., 1999). A high
and activates transcription. The Stat3-C molecule in proportion of head and neck cancers (often of squamous
immortalized fibroblasts causes cellular transforma- cell origin) have constitutively active Stat3, most likely
tion scored by colony formation in soft agar and tumor secondary to aberrant EGF receptor signaling (Grandis
formation in nude mice. Thus, the activated Stat3 mol- et al., 1998), and dominant-negative Stat3 slows the
ecule by itself can mediate cellular transformation and growth of cell lines developed from these cancers.
the experiments focus attention on the importance of Oncogenes were first defined as viral or mutated cellu-
constitutive Stat3 activation in human tumors. lar genes that could confer a transformed phenotype to
cultured cells (Lodish et al., 1995). When oncogenes
were characterized at the molecular level, many wereIntroduction
found to be constitutively activated. We set out to deter-
mine whether a constitutively active Stat3 moleculeSTAT (signal transducers and activators of transcription)
could transform cells independently of a tyrosine kinaseproteins are latent transcription factors that become
oncogene. One constitutively activated Stat moleculeactivated by phosphorylation on a single tyrosine (near
has been described. Amino acid changes in two sepa-residue 700), typically in response to extracellular li-
rate domains of Stat5 results in constitutive activationgands (Darnell, 1997; Stark et al., 1998). More than 40
and obviates the need for IL-3 in the growth of BaF3different polypeptide ligands cause STAT phosphoryla-
cells (Onishi et al., 1998). However, the amino acids thattion through either cytokine receptors plus associated
are changed in the Stat5 molecule (H-R299 and S-F711)Jak kinases or growth factors (e.g., EGF, PDGF, CSF1)
are not conserved between Stat5 and Stat3.acting through intrinsic receptor tyrosine kinases. An
The use of inserted cysteine residues to promote di-active Stat dimer is formed via the reciprocal interac-
merization has been used successfully in a number oftions between the SH2 domain of one monomer and the
signaling molecules. For example, the addition of thephosphorylated tyrosine of the other (Chen et al., 1998).
cysteine-dependent dimerization domains has beenThe dimers accumulate in the nucleus, recognize spe-
used in the extracellular regions to produce dimeric,cific DNA elements and activate transcription. The STAT
constitutively active receptors (Eyk, erythropoietin, c-Mpl;proteins are subsequently inactivated by tyrosine de-
Watowich et al., 1994; Alexander et al., 1995; Zong etphosphorylation and return to the cytoplasm (Haspel et
al., 1996). In addition the mobility of protein chains inal., 1996; R. L. Haspel and J. E. D., submitted).
ion channel proteins has been explored using insertedLigand-dependent activation of the STATs is often
cysteine residues to allow ªcysteine trappingº (Schulteis
associated with differentiation and/or growth regulation
et al., 1996; Benitah et al., 1997). Furthermore, the Pax
while constitutive activation of STATs (i.e., activation
transcription factors are regulated in the cell nucleus by
oxidation/reduction of conserved cysteine residues (Tell
et al., 1998). We have engineered a constitutively dimer-§ To whom correspondence should be addressed (e-mail: darnell@
rockvax.rockefeller.edu). izeable Stat3, termed Stat3-C, by substituting cysteine
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residues for specific amino acids within the C-terminal
loop in the SH2 domain of the Stat3 molecule. This
molecule is capable of driving transcription and induces
cell transformation, thus qualifying Stat3 as a protoon-
cogene.
Results
Design of a Constitutively Activated Stat3 Molecule
The crystal structures of Stat1 and Stat3 are virtually
superimposable. The DNA-bound dimers make pro-
tein:protein contact only in the SH2 domains. The phos-
photyrosine (residues 701 in Stat1 and 705 in Stat3)
of one monomer is extended on an z17±amino acid
unstructured tether to bind to the R602 (Stat1) or R608
(Stat3) in the SH2 pocket of its partner; a reciprocal
interaction completes the contacts between the two
monomers. In both the Stat1 and Stat3 homodimer,
there are loops just N-terminal to the COOH end of the
SH2 domain that are in close proximity to one another
(Figure 1A). We reasoned that substituting cysteine resi-
dues for A661 and N663 of the Stat3 molecule might
possibly allow for sulfhydryl bonds to form between
Stat3 monomers (Figures 1B and 1C) and render the
molecule capable of dimerizing without a phosphate on
Y705. Such a molecule, Stat3-C, was made by site-
directed mutagenesis of wild-type Stat3 to which an
epitope tag (FLAG) was also appended for ease in fol-
lowing the molecule in cells.
Biochemical Analysis of Stat3-C
Both wild-type Stat3 and mutant Stat3-C FLAG-tagged
proteins were introduced by transient transfection into
293T cells. Western blot analysis of nuclear extracts
from serum-grown cells transfected with Stat3-C re-
vealed production of a protein that was serine phosphor-
ylated but not tyrosine phosphorylated (Figure 2A). Stat3
taken from growing cells was phosphorylated on serine
without serum starvation (Wen et al., 1995; Zhu et al.,
1997). When the cDNA encoding the tyrosine kinase v-src
was cotransfected with either Stat3 or Stat3-C, both
molecules became tyrosine phosphorylated (Figure 2A).
Figure 1. The Crystal Structure of Stat1 and Cysteine BridgingThe monomers of Stat3-C migrated slightly faster than
through the C-Terminal Loop
wild-type Stat3 in SDS-PAGE. Electrophoretic mobility
(A) The C-terminal loops within the SH2 domain of a Stat1 homodi-shift analysis (EMSA) using nuclear extracts of these mer approach 6 AÊ of one another. The crystal structures of Stat1 and
cells and assaying binding to a high-affinity binding site Stat3 in this portion of the molecule are virtually superimposable.
(m67) for Stat3 was carried out both with and without (B) A661C and N663C mutations of the Stat3 molecule allow for
disulfide bridges to form in the C-terminal loops of the SH2 domainsv-src cotransfection. Without the v-src there was no
of two monomers (yellow).binding of wild-type Stat3 but there was constitutive
(C) A661 and N663 are conserved between Stat3, Stat1, and Stat4binding of Stat3-C to DNA (Figure 2B). In the cells cotrans-
in the C-terminal loop of the SH2 domain.
fected with v-src, the now tyrosine-phosphorylated wild-
type Stat3 bound to DNA (Figure 2B, lane 9). Also there
was increased binding to DNA in extracts from cells Nature of Stat3-C Dimer
transfected with Stat3-C plus v-src. Thus, either more If the Stat3-C dimerized through sulfhydryl bonds be-
dimers of Stat3-C formed when tyrosine phosphoryla- tween monomers, the formation of dimeric DNA-binding
tion was stimulated or the affinity for DNA was greater complexes should be inhibited by a reducing agent.
(Figure 2B, lane 11, see next section). The FLAG-tagged We incubated nuclear extracts containing either consti-
Stat3-C protein±DNA complexes could be supershifted tutively activated Stat3-C or tyrosine-phosphorylated
with anti-FLAG-antibody, while tyrosine-phosphorylated Stat3 (Stat3 from cells cotransfected with v-src) with
Stat3 protein that was not epitope tagged was not af- increasing concentrations of b-mercaptoethanol. Stat3-C
DNA binding as determined by EMSA was much morefected by this antiserum (Figure 2B, lane 14).
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Figure 2. Biochemical Analysis of Stat3-C Figure 3. Transcriptional Activity of Stat3-C
(A) Western blots from 293T-derived extracts. 293T cells were tran- (A) 293T cells were cotransfected with an m67 luciferase reporter
siently transfected with RcCMV (Rc), Stat3 (S3), Stat3-C (S3-C), v-src construct and RcCMV (Rc), Stat3 (S3), or Stat3-C (S3C). Some sam-
(vs), v-src with Stat3 (vs/S3), or v-src with Stat3-C (vs/S3-C). Twenty- ples (as indicated) were either cotransfected with v-src or treated
four hours later nuclear extracts were made from the transfected with IL-6 and soluble IL-6 receptor for 6 hr before assaying for
cells, separated by SDS-PAGE, and transferred to nitrocellulose luciferase activity. Results shown are the mean 6 SD of 3±5 experi-
membranes. The top blot was probed with anti-FLAG M2 antibody ments performed in triplicate.
(M2) (in this experiment both Stat3 and Stat3-C are FLAG-tagged (B) NIH3T3 or 3Y1 cells were transfected as described above and
at their COOH terminus), the middle blot with anti-phosphoserine cotransfected with v-src.
Stat3 antibody (S3 PS), and the bottom blot with anti-phosphotyro- (C) HepG2 cells were also transfected as described above. HepG2
sine Stat3 antibody (S3 PY). cells were not transfected with v-src.
(B) EMSA. The same extracts were incubated with a 32P-labeled
high-affinity binding site for Stat3 and resolved on a nondenaturing
susceptible to inhibition by b-mercaptoethanol thanpolyacrylamide gel. 1: RcCMV, 2: RcCMV/M2, 3: Stat3, 4: Stat3/M2,
5: Stat3-C, 6: Stat3-C/M2, 7: v-src, 8: v-src/M2, 9: Stat3/v-src, 10: wild-type protein (Figure 2C), supporting the conclusion
Stat3/v-src/M2, 11: Stat3-C/v-src, 12: Stat3-C/v-src/M2, 13: v-src that a sulfhydryl bond(s) between monomers was re-
transformed cells, 14: v-src transformed cells/M2. Alternate samples sponsible for Stat3-C dimerization and DNA binding.
were incubated with anti-FLAG M2 antibody as indicated. v-src
The relative affinity of both Stat3-C and tyrosine-phos-transformed cells containing tyrosine-phosphorylated wild-type
phorylated Stat3 for the high-affinity m67 DNA-bindingStat3 protein (non±FLAG tagged), was not affected by M2 antibody.
site was compared. Simultaneous addition of labeled(C) Competition with b-mercaptoethanol. Extracts containing Stat3-C
(S3-C) or tyrosine-phosphorylated Stat3 (S3/vs, v-src) were incu- and unlabeled oligonucleotide with nuclear extract pre-
bated with increasing amounts of b-mercaptoethanol (b-SH [nM]) vented Stat:DNA complex formation about equally (Fig-
and subsequently resolved on a nondenaturing polyacrylamide gel. ure 2Dii). We then tested the stability of preformed pro-
(D) Off rate of Stat3-C and Stat3 for m67. (i) Extracts containing tein:DNA complexes. Formation of a complex was
Stat3-C (S3-C) or tyrosine-phosphorylated Stat3 (S3/vs) (approxi-
allowed to occur between a fixed amount of nuclearmately equal total protein by Western blot) (ii) were incubated with
extract containing Stat3-C or phosphorylated Stat3 (Fig-2 ng or 10 ng of nonradiolabeled m67 then 1 ng of radiolabeled m67
ure 2Di, M2 Western) with labeled oligonucleotide (m67);and resolved on a nondenaturing polyacrylamide gel. (iii) These
same amounts of extract were incubated with 1 ng of radiolabeled then a 100-fold excess of unlabeled oligonucleotide was
m67 for 5 min followed by addition of a 100-fold greater amount of added to the preformed complex. Aliquots were with-
nonradiolabeled m67. Aliquots were removed before addition and drawn at intervals and immediately examined by loading
at indicated intervals after addition of unlabeled oligonucleotides
onto an electrophoresis gel. The dissociation of bothand loaded onto a continuously running nondenaturing polyacryl-
Stat3-C and Stat3 from the oligonucleotide were veryamide gel.
similar and the half time for dissociation was estimated
to be 17 min (Figure 2Diii).
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Table 1. Transformation AssayÐColonies in Soft Agar
NIH3T3 Transformation Assay 3Y1 Transformation Assay
Vector Colony Number (SD) Vector Colony Number (SD)
Rc 0 (0) Rc 0 (0)
Stat3 0 (0) Stat3 0 (0)
Stat3-C 12 (3) Stat3-C 10 (4)
V-src 68 (10) V-src 137 (23)
Plating Efficiency of Stable 3Y1-Derived Cell Lines
Cell Line Cell Number Colony Number
3Y1/Rc 106 0 (0)
S3-C(SA) 104 90 (10)
S3-C(G418) 104 110 (20)
v-src 103 100 (27)
Both NIH3T3 cells and 3Y1 cells were transfected with RcCMV, Stat3, Stat3-C, or v-src. Transfected cells (1 3 105) were plated in soft agar.
Three weeks later colony number was determined. Results shown are the mean 6 standard deviation (SD) of 3±8 experiments. The plating
efficiency of representative cell lines (either derived from soft agar [SA] or from clones selected in G418) was determined by plating the
indicated number of cells into soft agar and counting colonies after 4±10 days. Colonies 0.1 mm or greater were counted.
Stat3-C Activates Transcription Constitutively than NIH3T3 cell lines because of the occasional sponta-
neous transformation that is known to occur with NIH3T3Transient transfection of a reporter gene with Stat3 DNA-
binding sites into 293T, 3Y1, NIH3T3, and HepG2 cells cells. When examined by Western blots, all of the inde-
pendent cells lines established from soft agar colonieswas used to test transcriptional activation by Stat3 or
Stat3-C. Transcriptional activation was assayed both caused by Stat3-C (FLAG) expressed this protein (Fig-
ure 4A).with and without induction of tyrosine phosphorylation.
In order to induce tyrosine phosphorylation, cells were The nucleo-cytoplasmic distribution of the Stat3 mol-
ecules in the parent cell and transformed cells, as showneither treated with IL-6 plus soluble IL-6 receptor or
cotransfected with v-src, both of which phosphorylate in (Figure 4A), was of interest. Wild-type STAT molecules
are known to accumulate in the nucleus after phosphor-Stat3 and Stat3-C. Without any induced tyrosine phos-
phorylation, Stat3-C activated transcription of the re- ylation although the basis for this accumulation remains
unknown. That is, whether speedier import or slowerporter gene in all three cell lines approximately 10-fold
above background while the wild-type Stat3 did not export is responsible for the shift in distribution remains
unknown. Western blots of nuclear and cytoplasmic ex-induce transcription (Figure 3). Upon induction of tyro-
sine phosphorylation with either IL-6 or v-src, transcrip- tracts were compared using a Stat3 antiserum that de-
tects the preexistent wild-type Stat3 plus the newly in-tional stimulation by wild-type Stat3 now became evi-
dent and a further increase of Stat3-C-dependent corporated Stat3-C or using the anti-FLAG antiserum,
M2, that only detects Stat3-C. Equal amounts of proteintranscription also occurred. This latter result accorded
with the increase in DNA binding of Stat3-C after induc- from the nucleus and cytoplasm were used in this exper-
iment. In the untransformed 3Y1 cells, the cytoplasmiction of tyrosine phosphorylation (Figure 2B, lane 11).
We will return later to the question of transcriptional signal was similar to the nuclear signal, but since z90%
of the total cell protein is cytoplasmic this indicatesinduction by Stat3-C in permanently transformed cells
(Figure 6). most wild-type Stat3 is cytoplasmic without ligand stim-
ulation. However, extracts from the Stat3-C transformed
cells showed a considerably stronger nuclear than cyto-Characterization of Cell Lines Expressing Stat3-C
plasmic signal for Stat3. Also in the Stat3-C transformedIf Stat3-C can bind DNA and activate transcription with-
cells the nuclear anti-FLAG signal was greater than theout specific induction, we wished to determine whether
cytoplasmic. These results make it clear that comparedStat3-C could induce cellular transformation. NIH3T3
to wild-type protein the Stat3-C protein accumulates inand rat 3Y1 immortalized fibroblasts were transfected
the cell nucleus without ligand treatment of the cells.with the empty vector RcCMV, or the expression vector
The two Stat3 bands seen in Figure 4A are very likelyencoding Stat3, Stat3-C, or v-src and the transfected
the result of serine phosphorylation that is known to becells were plated for growth in soft agar. No trans-
responsible for two electrophoretically separable Stat3formants were detected with either RcCMV or wild-type
molecules (Boulton et al., 1995; Wen et al., 1995).Stat3 (Table 1). However, soft agar colonies were ob-
Extracts derived from stable cell lines expressingtained with Stat3-C at a frequency about 1/10 of that
Stat3-C (FLAG) exhibited constitutive binding to Stat3caused by v-src (Table 1). Cells were recovered from
DNA-binding sites (Figure 4B). Moreover, the amount ofthese transformed colonies and cultured so that they
DNA binding activity in the Stat3-C cells was about one-could be further analyzed for the presence of Stat3-C
half of that observed in a v-src transformed cell lineprotein, for constitutive transcriptional activity, and for
where the endogenous Stat3 is activated (Figure 4B,plating efficiency in soft agar in comparison to v-src
vsrc versus S3-C). Protein from these stable Stat3-transformed cells.
We chose to analyze 3Y1 transformed cell lines rather C-expressing cell lines has been precipitated by the
Stat3 as an Oncogene
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Table 2. Tumors in Nude Mice
Cell Line Tumor size (cm) cm3
3Y1 0 0
Stat3-C
Clone 21 0.4 3 0.5 3 1.0 0.2
0.5 3 0.5 3 1.0 0.25
0.3 3 0.9 3 1.0 0.3
Clone 1.4 2.0 3 1.0 3 0.5 1.0
1.5 3 1.0 3 1.0 1.5
1.0 3 2.0 3 0.5 1.0
v-src 2.0 3 3.0 3 3.5 21
4.0 3 2.0 3 2.0 16
3.3 3 2.1 3 2.3 16
Cells (1 3 106) from 3Y1, v-src and two independent Stat3-C cell
lines (21 and 1.4) were injected into the flank of 4- to 6-week-old
athymic nude (Balb-c nu/nu) mice. Each cell line was determined
in 3 different animals. Tumor size was determined 3 weeks after
injection.
number of colonies formed per cell plated (cloning effi-
ciency) was about 1/100 for Stat3-C and 1/10 for v-src
(Table 1, Table 2, and Figure 4D). Morphologically, the
soft agar colonies formed from Stat3-C cells were not
as dense as those formed with v-src (Figure 4D).
Cells Expressing Stat3-C Are Tumorigenic
When 106 cells from either of two Stat3-C clones were
injected subcutaneously into nude mice, tumors be-
came apparent at the site of injection within 2 to 4 weeks
(Table 2 and Figure 5A). No mice injected with parental
3Y1 cells developed tumors within an 8-week observa-
Figure 4. Stable Transformed Cell Lines Expressing Stat3-C tion period. v-src transformed 3Y1 cells exhibited a
(A) Nuclear and cytoplasmic extracts (10 mg each), from 3Y1 and stronger tumorigenic phenotype, developing larger tu-
Stat3-C (S3-C) transformed cells, were analyzed by Western blot, mors after 3 weeks (Table 2). Injection into nude mice
probed with anti-Stat3 antibody (S3), stripped, and reprobed with with cells transformed by v-Eyk (a receptor tyrosine ki-
anti-FLAG antibody (M2).
nase that also leads to constitutively active Stat3 in(B) Nuclear extracts from 3Y1, v-src, and Stat3-C (S3-C) were incu-
transformed cells) (Besser et al., 1999) caused develop-bated with radiolabeled m67 and resolved on a nondenaturing poly-
ment of tumors similar in size to those seen with Stat3-Cacrylamide gel. Stat3-C (S3-C) containing extracts are supershifted
with anti-FLAG (M2) antibody. (data not shown). Western blot analysis of extracts de-
(C) 3Y1, Stat3-C, or v-src transformed cell lines were transiently rived from Stat3-C-containing tumors reveal high levels
transfected with an m67 luciferase reporter construct. Twenty hours of FLAG-tagged Stat3-C protein (Figure 5B) showing
after transfection cells were harvested and assayed for luciferase
that the growing tumor cells retain this protein. Hema-activity (see Experimental Procedures). Results shown are the
toxalin and eosin staining of formalin fixed sections ofmean 6 SD of 3 experiments performed in triplicate.
v-src- or Stat3-C-derived tumors displayed somewhat(D) 3Y1, Stat3-C, and v-src transformed cell lines were plated in
dishes as well as in soft agar for morphological comparisons and different morphologies. The cells from Stat3-C-derived
the measurement of cloning efficiency. tumors had multiple nucleoli, large nuclei, and frequent
mitoses but were more spindle-like and appeared to be
more organized than the cells from the faster growing
v-src-derived tumors (Figure 5C). These differences are
FLAG epitope and shown to contain no detectable phos- similar to the morphological changes observed with the
photyrosine (data not shown). same cell lines grown adherently on plates (Figure 4D).
To examine the transcriptional stimulatory ability of
Stat3-C in the transformed cell lines, 3Y1-Stat3-C and Transcriptional Events Controlled by Stat3-C
v-src cell lines were transiently transfected with a lucifer- that May Be Related to Transformation
ase reporter gene containing Stat3 DNA-binding sites The transformation brought about by constitutively acti-
(m67 3 4; Figure 4C). Both cell lines transformed by vated Stat3-C presumably rests on transcription of
Stat3-C or by v-src gave constitutive transcriptional sig- genes regulated by Stat3 binding to regulatory regions.
nals that were approximately equal and significantly We have begun to analyze this question by two types
greater than in 3Y1 cells. of experiments: (a) an assay of the transcriptional activa-
We then directly compared the plating efficiency in tion of reporter genes bearing Stat3-dependent en-
soft agar of the newly established Stat3-C transformed hancer-containing chromosomal segments and (b) test-
ing for enhanced expression of genes that are knowncell lines relative to that of v-src transformed cells. The
Cell
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Figure 6. Stat3-C Gene Targets
(A) 293T cells were cotransfected with a rat a2-macroglobulin lucif-
erase reporter construct and RcCMV (Rc), Stat3 (S3), or Stat3-C
(S3-C). Some samples (as indicated) were treated with IL-6 and
soluble IL-6 receptor for 6 hr before assaying for luciferase activity.
Results shown are the mean 6 SD of 3 experiments performed in
duplicate.
(B) 293T cells were cotransfected with a human cyclin D1 luciferase
reporter construct and RcCMV (Rc), Stat3 (S3), or Stat3-C (S3-C).
Some samples (as indicated) were either cotransfected with v-src
or treated with IL-6 and soluble IL-6 receptor for 6 hr before assaying
for luciferase activity. Results shown are the mean 6 SD of 3 experi-
ments performed in duplicate.
(C) 3Y1, Stat3-C, or v-src transformed cell lines were transiently
transfected with a cyclin D1 luciferase reporter construct. Twenty
hours after transfection cells were harvested and assayed for lucifer-
ase activity (see Experimental Procedures). Results shown are the
mean 6 SD of 3 experiments peformed in duplicate.
(D) RNA was isolated from 3Y1, v-src, and Stat3-C (S3-C) trans-
formed cell lines. Northern blot analysis was performed. The mem-
brane was probed individually with cyclin D1, Bcl-XL, c-myc, and
Figure 5. Cells Expressing Stat3-C Are Tumorigenic GAPDH as a control for loading.
(A) A tumor in the flank of a nude mouse injected with Stat3-
C-containing cells (cell line 21). None are seen when 3Y1 cells are
injected.
reporter gene constructs introduced into 293T cells to(B) Whole cell extracts (20 mg) from a v-src- and Stat3-C-derived
test transcripitonal activation by Stat3-C (Figures 6Atumor and the corresponding cell lines were analyzed by Western
blot. One blot was probed with anti-Stat3 antibody (S3) the other and 6B). Stat3-C increased transcription 10-fold with
with anti-FLAG antibody (M2). the a2-macroglobulin construct and 40-fold with the
(C) Paraffin sections from v-src- and Stat3-C-containing tumors cyclin D1 construct without IL-6 treatment or v-src co-
were stained with hematoxalin and eosin and viewed at 403 and
transfection. Additional increases were seen after IL-61003 magnification.
treatment and or v-src cotransfection. We also exam-
ined the transcriptional stimulatory ability of Stat3-C in
the transformed cell lines. 3Y1, Stat3-C, and v-src cellto be connected either to growth control or apoptotic
events. lines were transiently transfected with the cyclin D1 lucif-
erase reporter gene. Both cell lines transformed byTranscription driven by the a2-macroglobulin en-
hancer is known to require both Stat3- and c-Jun-bind- Stat3-C or by v-src gave constitutive transcriptional sig-
nals that were significantly greater than in 3Y1 cellsing sites (Schaefer et al., 1995; Heinrich et al., 1998).
We have recently mapped regions of these two proteins (Figure 6C).
To test the effect of Stat3-C on endogenous genesthat engage in physical contact, very likley during en-
hanceosome stimulation of transcriptional activation (X. the mRNA levels of cyclin D1, Bcl-XL, and c-myc were
determined in Northern blots from untransformed 3Y1Zhang et al., submitted). In addition, it was recently
reported that a 4-fold transcriptional stimulation of the cells, and these same cells transformed by v-src or by
Stat3-C. There was a distinct increase (z3- to 5-fold) incyclin D1 promoter was achieved through Stat5 binding
(Matsumura et al., 1999). We used both the rat a2-mac- the concentration of each of these mRNAs (Figure 6D).
The possible physiologic meaning of these increases isroglobulin promoter (Hattori et al., 1990) and the human
cyclin D1 promoter DNA segments (Lee et al., 1999) in discussed below.
Stat3 as an Oncogene
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Discussion complex, strongly suggesting that the Cys±Cys interac-
tion occurred between the two monomers of a dimer.
Most important, the Stat3-C construct stimulated tran-During the past several years, reports have accumulated
indicating that human tumor samples contain constitu- scription from constructs with synthetic or authentic
Stat3-binding sites.tively activated Stats (1, 3, and 5 most frequently; re-
viewed in Garcia and Jove, 1998; Weber-Nordt et al., Cells bearing this Stat3-C construct acquire the trans-
formed phenotype scored by colony growth in soft agar1998). Likewise a consistent activation of Stat proteins,
particularly Stat3, has been described in cells trans- and by the ability to form tumors in nude mice. Although
neither the plating efficiency in soft agar nor the growthformed in culture by known oncogenes or in cell lines
started from human tumors. The requirement of Stat3 rate of the animal tumors equals that of v-src trans-
formed cells, the results nevertheless show that consti-activation for the maximal transformation of cells by
v-src was demonstrated using dominant-negative Stat3 tutively active Stat3 possesses oncogenic potential. The
events downstream from constitutively active Stat3 orto suppress transformation frequency and soft agar col-
ony formation (Bromberg et al., 1998; Turkson et al., 1998). Stat3-C that promote tumorgenesis are unclear but
could include enhancing conditions for cell cycle pro-In addition maximal growth rates of squamous carci-
noma cell lines was suppressed by expression of Stat3 gression and/or providing protection against apoptosis.
A large number of cell cycle regulators, both inhibitorsdominant-negative constructs (Grandis et al., 1998). All
of these observations suggest at least a supplementary or promoters of cycling, are now known and form one
important group of genes that might be affected byrole for constitutively active wild-type Stat3 in tumorgen-
esis. However, until the present studies, it remained an activated Stat3 molecule. In examining this class of
molecules we found that both cyclin D1 mRNA andunsettled whether constitutively active Stat3 could by
itself act as a transforming agent. c-myc mRNA were elevated 3- to 5-fold in Stat3-C trans-
formed cells compared to untransformed 3Y1 cellsSince wild-type Stat3 requires tyrosine phosphoryla-
tion for activation, persistent tyrosine phosphorylation (cyclin A mRNA was not elevated; data not shown). In
addition, transfection of the cyclin D1 promoter ap-by wild-type protein would be required for constitutive
activation. Sustained activation of wild-type Stat3 would pended to a luciferase reporter gene was transcription-
ally activated by Stat3-C in transfection experiments. Inappear logically to require a mutant protein that resists
dephosphorylation or a mutation that renders a recep- addition to positive effectors (or inhibitors of negative
effectors) of cell cycle regulation, inducible genes thattor±kinase complex continually active. Lacking knowl-
edge of how to effect either of these changes, we aimed affect apoptosis are also crucial in the survival of trans-
formed cells (Adams and Cory, 1998; Cory et al., 1999).to effect activation (dimerization and DNA binding) with-
out tyrosine phosphorylation by the insertion of cys- Stat3 has been clearly demonstrated to have an anti-
apoptotic role in T cells and in monocytes during theirteines in the SH2 domain. It appeared that the amino
acid loops downstream from the crucial R608 (the phos- differentiation. Induction of Stat32/2 precursor cells in
these lineages leads to cell death of the Stat32/2 cellsphotyrosine-binding site in the SH2 domain) afforded a
region of close proximity of the two chains into which (Takeda et al., 1998, 1999). Likewise, cultured human
multiple myeloma cells that have incorporated a Stat3cysteines might be introduced with the desired effect.
While sulhydryls do not form easily in the reducing in- dominant-negative gene undergo apoptosis (Catlett-
Falcone et al., 1999). And we found that Stat3-C trans-tracellular milieu, it is not an unknown event. For exam-
ple, there is regular formation of interchain cysteine± formed cells had elevated levels of Bcl-XL mRNA. Thus,
transformation by constitutively active Stat3 may gener-cysteine bridging in immunoglobulin formation. Also,
sulhydryls can form intrachain bonds at considerable ally contribute to stimulating cell cycle progression and
provide protection against apoptosis.distances within a chain. The frequency of such intra-
chain links has even been used to estimate the radius The present experiments both provide the tools to
pursue the basis of Stat3 transformation and heightenwith which two cysteines must come in proximity (4.5 AÊ )
to result in high rates of cysteine±cysteine interaction interest in constitutively active Stat3, found in so many
human tumor samples. Furthermore, constitutively ac-(Benitah et al., 1997). Finally, it is known that crucial
cysteine residues function in the intranuclear regulation tive Stat3 presents an attractive target for drug discov-
ery with the potential of inducing cell death or inhibitingof Pax transcription factors. Since we do not know accu-
the growth of human cancer cells.rately the intracellular status of STAT molecules, we
assumed that proximity of these molecules might some-
Experimental Procedureshow allow disulfide bridges to form. It has, for example,
been reported that some Stat3 nonphosphorylated di-
Cell Lines, Transfections, and Luciferase Measurementsmers exist in cells without ligand stimulation and this
NIH3T3, 293T, and HepG2 cells were obtained from the American
might allow for cysteine±cysteine cross-links (Novak et Type Culture Collection. 3Y1 cells (Kimura et al., 1975), v-src, and
al., 1998). In our experiments, success of spontaneous v-eyk transformed NIH3T3 and 3Y1 cells were a generous gift from
dimer formation was judged by the appearance of H. Hanafusa and D. Besser (Rockefeller University). All cells were
grown in Dulbecco's modified Eagle's medium (DMEM) containingStat3-C DNA binding to known Stat3 binding sites. The
10% Cosmic Calf serum (HyClone). Total cell extracts and nuclearoff-time of the Stat3-C on single Stat3-binding sites was
and cytoplasmic factors were prepared as described with the exclu-equal in wild-type and mutant protein making it highly
sion of NP-40 in the cytoplasmic extract buffer (Shuai et al., 1992;
likely that only dimeric molecules bound. However, the Wen et al., 1995). Lipofectamine Plus (Life Technologies) or Su-
sensitivity of the DNA-bound form of Stat3-C to reducing perfect (Qiagen) was used for transfections. Typically, for a 35 mm
diameter dish containing 1 3 105 cells, 1 mg of each plasmid to beagents was greater than to the wild-type protein:DNA
Cell
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transfected was utilized. For IL-6 induction experiments, 20 hr after [Pharmacia Biotech]). Dissociation rate determination was per-
formed as previously described (Vinkemeier et al., 1996). RNA wastransfection of luciferase-containing reporter genes, human IL-6
(Boehringer Mannheim) was used at a concentration of 500 U/ml isolated using Trizol Reagent (GIBCO-BRL). Northern blots were
performed as previously described (Ausubel et al., 1994). The humanand recombinant soluble form of the human IL-6 receptor (R&D
Systems) was used at 5 ng/ml for approximately 6 hr prior to prepar- cyclin D1 probe was a gift from Richard Pestell. The human Bcl-XL
probe was a gift from Gabriel Nunez (Univ. of Michigan) and theing extracts. Luciferase assays were performed using the dual-lucif-
erase reporter system (Promega), and all the results shown indicate murine c-myc construct was a gift from Ken Marcu (SUNY Stony
Brook).luciferase activities normalized against an internal control luciferase
reporter of Renilla luciferase (Promega).
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